Up next

Osteoporosis Medications Part 2 – Test Prep and Practice Pearls

Bisphosphonates are commonly used to treat osteoporosis, but several non-bisphosphonate osteoporosis medications can help reduce fracture risk. Pharmacists should understand the mechanisms, adverse effects, and clinical pearls associated with these alternatives. On this podcast e ...  Show more

Osteoporosis Medications – Test Prep and Practice Pearls: Bisphosphonates

Bisphosphonates are commonly used to prevent and treat osteoporosis, making them an important topic for pharmacy, nursing, and medical exams. In this episode of the Real Life Pharmacology Podcast, we review high-yield bisphosphonate facts and practical pearls to help you prepare ...  Show more

Recommended Episodes

Is Pharmacology Difficult Podcast ALPHA RECEPTOR ANTAGONISTS -YOHIMBINE, BUNAZOSIN, URAPIDIL, INDORAMIN, ETC.
IS PHARMACOLOGY DIFFICULT®️ Podcast

Would love to know your opinions & expectations -Dr Radhika VijayWelcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay.In this episode, I will be continuing and concluding my talk about few more "ALPHA RECEPTOR ANTAGONISTS", like Yohimbine, Indoramin, Urapidil, ...  Show more

Is Pharmacology Difficult Podcast FEW DETAILS & ADVERSE DRUG REACTIONS OF BETA RECEPTOR AGONIST DRUGS
IS PHARMACOLOGY DIFFICULT®️ Podcast

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay. In this episode, I will be first and foremost gathering few leftover conversation pieces about Ritodrine and Mirabegron, Beta 2 and Beta 3 receptor selective agonists respectively. Secondly I will be summari ...  Show more

Is Pharmacology Difficult Podcast ALPHA RECEPTOR ANTAGONISTS -YOHIMBINE, BUNAZOSIN, URAPIDIL, INDORAMIN, ETC.
IS PHARMACOLOGY DIFFICULT®️ Podcast

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay. In this episode, I will be continuing and concluding my talk about few more "ALPHA RECEPTOR ANTAGONISTS", like Yohimbine, Indoramin, Urapidil, Ergot Alkaloids, Ketanserin, Bunazosin, etc.  I will be discussi ...  Show more